GleamWall
中文EN

ZYME Zymeworks Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1937653 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY97.8%
TTM net income YoY168.3%
TTM EPS YoY162.4%
Revenue 3-yr CAGR-16.8%
Net income 3-yr CAGR-40.5%

Margins

Gross margin—
Operating margin16.6%
Net margin16.3%
FCF margin-42.4%
EBITDA margin18.0%

Returns

ROE15.0%
ROA5.5%
ROIC (approx.)11.7%
Asset turnover0.34x

Leverage & solvency

Liabilities / assets78.0%
Debt / equity1.31x
Current ratio3.30x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-2.59x
Accruals ratio19.7%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$105.97M$76.30M
R&D expense$137.00M$134.62M
SG&A expense$61.51M$61.51M
Operating income-$92.55M-$137.11M
Pretax income-$79.75M-$116.61M
Income tax$1.38M$6.08M
Net income-$81.13M-$122.69M
EBITDA-$88.88M-$132.92M
EPS (basic)-1.08-1.62
EPS (diluted)-1.08-1.62
Weighted avg. shares (diluted)75.41M75.88M
Balance sheet
Cash & equivalents$41.16M$66.10M
Receivables$4.64M$55.81M
Current assets$248.77M$300.45M
PP&E, net$15.50M$17.65M
Goodwill$12.02M$12.02M
Intangibles$1.35M$4.58M
Total assets$346.53M$463.09M
Current liabilities$42.32M$88.29M
Total liabilities$78.03M$124.32M
Shareholders' equity$268.50M$338.77M
Shares outstanding74.64M68.96M
Cash flow statement
Operating cash flow-$33.01M-$110.06M
Capital expenditure$1.52M$1.99M
Free cash flow-$34.53M-$112.05M
Investing cash flow$26.66M$38.76M
Financing cash flow-$18.56M-$20.44M
Depreciation & amortization$3.67M$4.19M
Stock-based compensation$28.03M$17.79M
Share buybacks$41.70M$30.05M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.